[Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)]36599

Last updated on 23-8-2019 by Anonymous (not verified)

Public Access


Peer reviewed scientific article



Cefotaxime was used to treat 33 patients with serious Gram-negative bacillary infections. The dosage varied between 1.5 g and 4 g/day in patients without renal failure. Eighteen patients had urinary tract infections, 6 had pulmonary infections and 10 had miscellaneous infections. Sixteen patients were also bacteremic. Twenty-five infections were due to pathogens resistant to ampicillin, cephalothin, gentamicin and/or tobramycin, in vitro. Fifteen infections had failed to resolve during ampicillin, cefazolin, gentamicin or tobramycin therapy. Thirty-two patients responded favourably (cure or…

Associated health topics:

QR code

QR code for this page URL